New bioactive halenaquinone derivatives from South Pacific marine sponges of the genus Xestospongia

Bioorg Med Chem. 2010 Aug 15;18(16):6006-11. doi: 10.1016/j.bmc.2010.06.066. Epub 2010 Jun 25.

Abstract

Bioassay-directed fractionation of South Pacific marine sponges of the genus Xestospongia has led to the isolation of a number of halenaquinone-type polyketides, including two new derivatives named xestosaprol C methylacetal 7 and orhalquinone 8. Chemical characterization of these two new compounds was achieved by extensive 1D and 2D NMR spectroscopic studies. Evaluation of anti-phospholipase A(2), anti-farnesyltransferase and antiplasmodial activities of this series is presented and structure/activity relationships are discussed. Orhalquinone 8 displayed a significant inhibition of both human and yeast farnesyltransferase enzymes, with IC(50) value of 0.40 microM and was a moderate growth inhibitor of Plasmodium falciparum.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antimalarials / chemistry*
  • Antimalarials / isolation & purification
  • Antimalarials / pharmacology*
  • Cell Survival / drug effects
  • Chlorocebus aethiops
  • Farnesyltranstransferase / antagonists & inhibitors*
  • Farnesyltranstransferase / metabolism
  • Humans
  • Malaria, Falciparum / drug therapy
  • Phospholipase A2 Inhibitors*
  • Phospholipases A2 / metabolism
  • Plasmodium falciparum / drug effects*
  • Quinones / chemistry*
  • Quinones / isolation & purification
  • Quinones / pharmacology*
  • Structure-Activity Relationship
  • Vero Cells
  • Xestospongia / chemistry*
  • Yeasts / enzymology

Substances

  • Antimalarials
  • Phospholipase A2 Inhibitors
  • Quinones
  • halenaquinone
  • Farnesyltranstransferase
  • Phospholipases A2